Skip to main content
SpringerLink
Log in

Adverse Effects of Anabolic Steroids

  • Adverse Drug Experience Review
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

Anabolic steroids are used therapeutically for various disorders and as ergogenic aids by athletes to augment strength, muscular development, and to enhance performance. There is a wide range of concomitant temporary and permanent adverse effects with steroid administration. Several well-documented adverse actions of these hormones may develop rapidly within several weeks or less (i.e. altered reproductive function) or require up to several years of steroid intake (i.e. liver carcinoma). More recent studies indicate that glucose intolerance, insulin resistance, increased cardiovascular disease risk profiles, cerebral dangers, musculoskeletal injuries, prostate cancer, psychosis and schizophrenic episodes, among others, accompany anabolic steroid intake. There is, at present, no evidence to support the claim that athletes are less susceptible to adverse effects than those individuals receiving hormone treatment in a clinical setting. Based on the available information which has accumulated primarily from cross-sectional, short term longitudinal, and case studies, there is a need: (a) to develop a comprehensive battery of specific and sensitive markers of adverse effects, particularly those that would be able to detect the onset of adverse actions; and (b) to conduct controlled long term longitudinal studies in order to fully understand the extensiveness and mechanisms involved in the occurrence of adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aakvaag A, Vogt JH. Plasma testosterone values in different forms of testosterone treatment. Acta Endocrinologica 60: 537–542, 1969

    PubMed  CAS  Google Scholar 

  • Abbott WE, Hirschfeld JW, Williams HH, Pilling MA, Meyer FL. Metabolic alterations following thermal burns. Surgery 20: 284–294, 1946

    PubMed  CAS  Google Scholar 

  • Aloia JF, Kapoor A, Vaswani A, Cohn SH. Changes in body composition following therapy of osteoporosis with methandrostenolone Metabolism 30: 1076–1079, 1981

    CAS  Google Scholar 

  • Annitto WJ, Layman WA. Anabolic steroids and acute schizophrenic episode. Journal of Clinical Psychiatry 41: 143–144, 1980

    PubMed  CAS  Google Scholar 

  • Anthony PP. Hepatoma associated with androgenic steroids. Lancet 1: 685–686, 1975

    PubMed  CAS  Google Scholar 

  • Appel H-J, Heller-Umpfenbach B, Feraudi M, Weicker H. Ultrastructural and morphometric investigations on the effects of training and administration of anabolic steroids on the myocardium of guinea pigs. International Journal of Sports Medicine 4: 268–274, 1983

    Google Scholar 

  • Baker PJ, Ramey ER, Ramwell PW. Androgen-mediated sex differences of cardiovascular responses in rats. American Journal of Physiology 235: H242–H246, 1978

    PubMed  CAS  Google Scholar 

  • Behrendt H. Effect of anabolic steroids on rat heart muscle cells. I. Intermediate filaments. Cell Tissue Research 180: 303–315, 1977

    CAS  Google Scholar 

  • Behrendt H, Boffin H. Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Research 181: 423–426, 1977

    PubMed  CAS  Google Scholar 

  • Berg A, Ringwald G, Keul J. Lipoprotein-cholesterol in well-trained athletes: a preliminary communication: reduced HDL cholesterol in power athletes. International Journal of Sports Medicine 1: 137–138, 1980

    CAS  Google Scholar 

  • Bergink EW, Geelen JAA, Turpijn EW. Metabolism and receptor binding of nandrolone and testosterone under in vitro and in vivo conditions. Acta Endocrinologica (Suppl. 271): 31–37, 1985

  • Bernstein MS, Hunter RL, Yachmin S. Hepatoma and peliosis hepatis developing in a patient with Fanconi’s anemia. New England Journal of Medicine 284: 1135–1136, 1971

    PubMed  CAS  Google Scholar 

  • Bhargava KP, Dhawan KN, Saxena RC. Enhancement of noradrenaline pressor responses in testosterone-treated cats. British Journal of Pharmacology and Chemotherapy 31: 26–31, 1967

    PubMed  CAS  Google Scholar 

  • Bierly JR. Use of anabolic steroids by athletes: do the risks outweight the benefits? Postgraduate Medicine 82: 67–74, 1987

    PubMed  CAS  Google Scholar 

  • Bijlsma JWJ, Duursma SA, Bosch R, Huber O. Lack of influence of the anabolic steroid nandrolone decanoate on bone metabolism. Acta Endocrinologica 101: 140–143, 1982

    PubMed  CAS  Google Scholar 

  • Bird D, Vowles K, Anthony PP. Spontaneous rupture of a liver cell adenoma after long-term methyltestosterone: report of a case successfully treated by emergency right hepatic lobectomy. British Journal of Surgery 66: 212–213, 1979

    PubMed  CAS  Google Scholar 

  • Boyd PR, Mark GV. Multiple hepatic adenomas and a heptocellular carcinoma in a man on oral methyltestosterone for eleven years. Cancer 40: 1765–1770, 1977

    PubMed  CAS  Google Scholar 

  • Bradshaw JS, Abbott WE, Levey S. The use of anabolic steroids in surgical patients. American Journal of Surgery 99: 600–607, 1960

    PubMed  CAS  Google Scholar 

  • Brämswig JH, Nieschlag E, Schellong G. Pituitary-gonadal function in boys after high dose testosterone treatment for excessively tall stature. Acta Endocrinologica 107: 97–103, 1984

    PubMed  Google Scholar 

  • Brämswig JH, Schellong G, Borger H-J, Breu H. Testosteron-Therapie hochwuchsiger Jungen Ergebnisse bei 25 Jungen. Deutsch Medizinische Wochenschrift 106: 1656–1661, 1981

    Google Scholar 

  • Bruguera M. Hepatoma associated with androgenic steroids. Lancet 2: 1294–1295, 1975

    Google Scholar 

  • Burstein S, Grumbach MM, Kaplan SD. Early determination of androgen-responsiveness is important in the management of microphallus. Lancet 2: 983–986, 1979

    PubMed  CAS  Google Scholar 

  • Camerino B, Sala G. Anabolic steroids. Progress in Drug Research 2: 71–134, 1960

    PubMed  CAS  Google Scholar 

  • Caminos-Torres R, Ma L, Snyder PJ. Testosterone-induced inhibition of the LH and FSH responses to gonadotropin-releasing hormone occurs slowly. Journal of Clinical Endocrinology and Metabolism 44: 1142–1153, 1977

    PubMed  CAS  Google Scholar 

  • Capaccio JA, Kurowski TT, Czerwinski SM, Chatterton Jr RT, Hickson RC. Testosterone fails to prevent skeletal muscle atrophy from glucocorticoids. Journal of Applied Physiology 63: 328–334, 1987

    PubMed  CAS  Google Scholar 

  • Carrasco D, Pallardo L, Prieto M, Moll JL, Cruz JM, Berenguer J. Hepatic adenomata and androgen treatment. Annals of Internal Medicine 100: 316, 1984

    PubMed  CAS  Google Scholar 

  • Carrasco D, Prieto M, Pallardo L, Moll JL, Cruz JM, et al. Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Journal of Hepatology 1: 573–578, 1985

    PubMed  CAS  Google Scholar 

  • Carter CH. The anabolic steroid, stanozolol: its evaluation in debilitated children. Clinical Pediatrics 4: 671–680, 1965

    PubMed  CAS  Google Scholar 

  • Castelli WP, Doyle JI, Gordon T, Hines CG, Hjortland MC, et al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 55: 767–772, 1977

    PubMed  CAS  Google Scholar 

  • Chatterton RT. Inactivation and excretion of steroids. In Zaneveld & Chatterton (Eds) Biochemistry of mammalian reproduction, pp. 501–506, John Wiley & Sons, New York, 1982

    Google Scholar 

  • Cheesman KL. Steroid hormones: biosynthesis, secretion, and transport. In Zaneveld & Chatterton (Eds) Biochemistry of mammalian reproduction, pp. 401–454, John Wiley & Sons, New York, 1982

    Google Scholar 

  • Clarkson PM, Hintermister, R, Fillyaw M, Stylos L. High density lipoprotein cholesterol in young adult weight lifters, runners, and untrained subjects. Human Biology 53: 251–257, 1981

    PubMed  CAS  Google Scholar 

  • Clerico A, Ferdeghini M, Palombo C, Leoncini R, Delchicca MG, et al. Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training. Journal of Nuclear Medicine and Allied Sciences 23: 79–88, 1981

    Google Scholar 

  • Cocks JR. Methyltestosterone-induced liver-cell tumors. Medical Journal of Australia 2: 617–618, 1981

    PubMed  CAS  Google Scholar 

  • Cohen JC, Hickman R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. Journal of Clinical Endocrinology and Metabolism 64: 960–963, 1987

    PubMed  CAS  Google Scholar 

  • Coombes GB, Reiser J, Paradinas FJ, Burn I. An androgen-associated hepatic adenoma in a transexual. British Journal of Surgery 65: 869–870, 1978

    PubMed  CAS  Google Scholar 

  • Creagh TM, Rubin A, Evans DJ. Hepatic tumours induced by anabolic steroids in an athlete. Journal of Clinical Pathology 41: 441–443, 1988

    PubMed  CAS  Google Scholar 

  • Davidson JM, Camargo CA, Smith ER. Effects of androgen on sexual behavior in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 48: 955–958, 1979

    PubMed  CAS  Google Scholar 

  • Dhem A, Ars-Piret N, Waterschoot MP. The effects of nandrolone decanoate on rarefying bone tissue. Current Medical Research and Opinion 6: 606–613, 1980

    PubMed  CAS  Google Scholar 

  • Doerr P, Pirke KM. Regulation of plasma oestrogens in normal adult males. Acta Endocrinologica 75: 617–624, 1974

    PubMed  CAS  Google Scholar 

  • Dorfman RI, Kincl FA. Relative potency of various steroids in an anabolic-androgenic assay using the castrated rat. Endocrinology 72: 259–266, 1963

    CAS  Google Scholar 

  • Evans RG. Methandienone in long-term cortiscosteroid therapy. Acta Allergologica 17: 220–231, 1962

    PubMed  CAS  Google Scholar 

  • Evans WJ, Ivy JL. Effects of testosterone propionate on hindlimb immobilized rats. Journal of Applied Physiology 52: 1643–1647, 1982

    PubMed  CAS  Google Scholar 

  • Fahey TD, Brown CH. The effects of an anabolic steroid on the strength, body composition and endurance of college males when accompanied by a weight training program. Medicine and Science in Sports 5: 212–216, 1973

    Google Scholar 

  • Falk H, Thomas LB, Popper H, Ishak KG. Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 2: 1120–1123, 1979

    PubMed  CAS  Google Scholar 

  • Farrel GC, Joshua DE, Uren RF, Baird PJ, Perkins KW, et al. Androgen-induced hepatoma. Lancet 1: 430–432, 1975

    Google Scholar 

  • Farrell PA, Maksud MG, Pollock ML, Foster C, Anholm J, et al. A comparison of plasma cholesterol, triglycerides, and high density lipoprotein cholesterol in speed skaters, weightlifters, and nonathletes. European Journal of Applied Physiology 48: 77–82, 1982

    CAS  Google Scholar 

  • Foglia VG, Basabe JC, Chieri R. Evolution of diabetes after early testosterone treatment in rats. Diabetologia 5: 258–259, 1969

    PubMed  CAS  Google Scholar 

  • Foglia VG, Schuster N, Rodriguez RR. Sex and diabetes. Endocrinology 41: 428–433, 1947

    PubMed  CAS  Google Scholar 

  • Foss GL. The oral application of methyltestosterone and its simplification of androgen therapy. British Medical Journal 1: 11–12, 1939

    Google Scholar 

  • Foss GL, Simpson SL. Oral methyltestosterone and jaundice. British Medical Journal 1: 259, 1959

    PubMed  CAS  Google Scholar 

  • Frankle MA, Eichberg R, Zachariah SB. Anabolic androgenic steroids and a stroke in an athlete. Archives of Physical Medicine and Rehabilitation 69: 632–633, 1988

    PubMed  CAS  Google Scholar 

  • Freed DLJ, Banks AJ, Longson D, Burley I. Anabolic steroids in athletics: crossover double-blind trial on weightlifters. British Medical Journal 2: 471–473, 1975

    PubMed  CAS  Google Scholar 

  • Goldfarb S. Sex hormones and hepatic neoplasia. Cancer Research 36: 2584–2588, 1976

    PubMed  CAS  Google Scholar 

  • Goldman B. Liver carcinoma in an athlete taking anabolic steroids. Journal of the American Osteopathic Association 85: 56, 1985

    PubMed  CAS  Google Scholar 

  • Greenberg S, George WR, Kadowitz PJ, Wilson WR. Androgen-induced enhancement of vascular reactivity. Canadian Journal of Physiology and Pharmacology 52: 12–22, 1974

    Google Scholar 

  • Gribbin HR, Flavell-Matts SG. Mode of action and use of anabolic steroids. British Journal of Clinical Practice 30: 3–9, 1976

    PubMed  CAS  Google Scholar 

  • Guyda H, Friesen H, Bailey JD, Leboeuf G, Beck JC. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy. Canadian Medical Association Journal 112: 1301–1309, 1975

    PubMed  CAS  Google Scholar 

  • Haffner SM, Hushwaha RS, Foster DM. Studies on the metabolic mechanism of reduced high-density lipoproteins during anabolic-steroid therapy. Metabolism 32: 413–420, 1983

    PubMed  CAS  Google Scholar 

  • Hagerman FC, Jones-Witters P, Ranson R. The effects of anabolic steroid ingestion on serum enzyme and urine 17-ketosteroid levels. Journal of Sports Medicine 15: 287–295, 1975

    CAS  Google Scholar 

  • Hartmann G, Addicks K, Donike M, Schanzer W. Testosterone application influences sympathetic activity of intracardial nerves in non-trained and trained mice. Journal of Autonomic Nervous System 17: 85–100, 1986

    CAS  Google Scholar 

  • Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. American Journal of Sports Medicine 12: 469–484, 1984

    PubMed  CAS  Google Scholar 

  • Heath GW, Ehsani AA, Hagberg JM, Hinderliter JM, Goldberg AP. Exercise training improves lipoprotein lipid profiles in patients with coronary artery disease. American Heart Journal 105: 889–895, 1983

    PubMed  CAS  Google Scholar 

  • Henderson JT, Richmond J, Sommerling MD. Androgenic-anabolic steroid therapy and hepatocellular carcinoma. Lancet 1: 934, 1973

    PubMed  CAS  Google Scholar 

  • Hernandez-Nieto L, Brugera M, Bombi JA, Comacho L, Rozman C. Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone). Cancer 40: 1761–1764, 1977

    PubMed  CAS  Google Scholar 

  • Hervey GR, Knibbs AV, Burkinshaw L, Morgan DB, Jones PRM, et al. Effects of methandienone on the performance and body composition of men undergoing athletic training. Clinical Science 60: 457–461, 1981

    PubMed  CAS  Google Scholar 

  • Hickson RC, Galassi TM, Kurowski TT, Daniels DG, Chatterton Jr RT. Androgen and glucocorticoid mechanisms in exercise-induced cardia hypertrophy. American Journal of Physiology 246 (Heart Circulation and Physiology 15): H761–767, 1984

    PubMed  CAS  Google Scholar 

  • Hickson RC, Kurowski TG. Anabolic steroids and training. Clinics in Sports Medicine 5: 461–469, 1986

    PubMed  CAS  Google Scholar 

  • Hickson RC, Kurowski TT, Andrews GH, Capaccio JA, Chatterton Jr RT. Glucocorticoid cytosol binding in exercise-induced sparing of muscle atrophy. Journal of Applied Physiology 60: 1413–1419, 1986

    PubMed  CAS  Google Scholar 

  • Holder LE, Gnarra DJ, Lampkin BC, Nishiydama H, Perkins P. Hepatoma associated with anabolic steroid therapy, case study, 10 yr. old male patient. American Journal of Roentgenology 124: 638–643, 1975

    CAS  Google Scholar 

  • Holma P. Effect of an anabolic steroid (methandienone) on central and peripheral blood flow in well-trained male athletes. Annals in Clinical Research 9: 215–221, 1977

    CAS  Google Scholar 

  • Honrath WL, Wolff A, Meli A. The influence of the amount of solvent (sesame oil) on the degree and duration of action of subcutaneously administered testosterone and its propionate. Steroids 2: 425–428, 1963

    CAS  Google Scholar 

  • Hurley BF, Seals DR, Hagberg JH, Goldberg AC, Ostrove SM, et al. High-density-lipoprotein cholesterol in bodybuilders v powerlifters: negative effects of androgen use. Journal of the American Medical Association 252: 507–513, 1984

    PubMed  CAS  Google Scholar 

  • Ishak GI. Hepatic lesions caused by anabolic and contraceptive steroids. Seminars in Liver Disease 1: 116–128, 1981

    PubMed  CAS  Google Scholar 

  • Jackson ST, Rallison ML, Buntin WH, Johnson SB, Flynn RR. Use of oxandrolone for growth stimulation in children. American Journal of Diseases in Children 126: 481–484, 1973

    CAS  Google Scholar 

  • James KC, Nicholls PJ, Roberts M. Biological half-lives of [4-14 C] testosterone and some of its esters after injection into the rat. Journal of Pharmacy and Pharmacology 21: 24–27, 1969

    PubMed  CAS  Google Scholar 

  • Johnson FL. The association of oral androgenic-anabolic steroids and life-threatening disease. Medicine and Science in Sports 7: 284–286, 1975

    PubMed  CAS  Google Scholar 

  • Johnson FL, Feagler JR, Lerner KG, Majerus PW, Siegel M, et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 2: 1273–1276, 1972

    PubMed  CAS  Google Scholar 

  • Johnson LC, Fisher G, Silvester LJ, Hofheins CC. Anabolic steroid: effects on strength, body weight, oxygen uptake and spermatogenesis upon mature males. Medicine and Science in Sports 4: 43–45, 1972

    PubMed  CAS  Google Scholar 

  • Johnson LC, O’Shea JP. Anabolic steroid: effects on strength development. Science 164: 957–959, 1969

    PubMed  CAS  Google Scholar 

  • Junkmann K. Long-acting steroids in reproduction. Recent Progress in Hormone Research 13: 389–419, 1957

    PubMed  CAS  Google Scholar 

  • Kalliomaki JL, Pirila AM, Ruikka I. A therapeutic trial with ethylestrenol in geriatric patients. Acta Endocrinologica (Suppl.) 63: 124–128, 1962

    Google Scholar 

  • Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham study. Annals of Internal Medicine 90: 85–91, 1979

    PubMed  CAS  Google Scholar 

  • Keele DK, Worley JW. Study of an anabolic steroid: certain effects of oxymetholone on small children. American Journal of Diseases in Children 113: 422–430, 1967

    CAS  Google Scholar 

  • Kew MC, Van Coller B, Prowse CM, Skikne B, Wolfsdorf JI, et al. Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. South African Medical Journal 50: 1233–1237, 1976

    PubMed  CAS  Google Scholar 

  • Kilshaw BH, Harkness RA, Hobson BM, Smith AWM. The effects of large doses of the anabolic steroid, methandrostenolone, on an athlete. Clinical Endocrinology 4: 537–541, 1975

    PubMed  CAS  Google Scholar 

  • Kochakian CD. Effect of male hormone on protein metabolism of castrate dogs. Proceedings of the Society for Experimental Biology and Medicine 32: 1064–1065, 1935

    Google Scholar 

  • Koenig H, Goldstone A, Lu CY. Testosterone-mediated sexual dimorphism of the rodent heart: ventricular lysosomes, mitochondria, and cell growth are modulated by androgens. Circulation Research 50: 782–787, 1982

    PubMed  CAS  Google Scholar 

  • Kopera H. The history of anabolic steroids and a review of clinical experience with anabolic steroids. Acta Endocrinologica (Suppl. 271): 11–18, 1985

  • Kory RC, Bradley MH, Watson RN, Callahan R, Peters BJ. A six-month evaluation of an anabolic drug. Norethandrolone, in underweight persons. II. Bromsulphalein (BSP) retention and liver function. American Journal of Medicine 26: 243–248, 1959

    CAS  Google Scholar 

  • Kramhoft M, Solgaard S. Spontaneous rupture of the extensor pollicis longus tendon after anabolic steroids. Journal of Hand Surgery 11: 87, 1986

    CAS  Google Scholar 

  • Krieg M, Smith K, Bartsch W. Demonstration and a specific androgen receptor in rat heart muscle: relationship between binding, metabolism and tissue levels of androgens. Endocrinology 103: 1686–1694, 1978

    PubMed  CAS  Google Scholar 

  • Lamb DR. Anabolic steroids in athletics: how well do they work and how dangerous are they? American Journal of Sports Medicine 12: 31–38, 1984

    PubMed  CAS  Google Scholar 

  • Lennon HD, Saunders FJ. Anabolic activity of 2-oxa-17α-methyldihydrotestosterone (oxandrolone) in castrated rats. Steroids 4: 689–697, 1964

    CAS  Google Scholar 

  • Lesna M, Spencer I, Walker W. Liver nodules and androgens. Lancet 2: 1124, 1976

    Google Scholar 

  • Liao S, Liang T, Fang S, Casteneda E, Shao TC. Steroid structure and androgenic activity. Journal of Biological Chemistry 248: 6154–6162, 1973

    PubMed  CAS  Google Scholar 

  • Liddle GW, Burke HA. Anabolic steroids in clinical medicine. Helvetica Medica Acta 27: 504–513, 1960

    PubMed  CAS  Google Scholar 

  • Limbeck GA, Ruvalcaba RHA, Mahoney CP, Kelley VC. Studies on anabolic steroids: IV. The effects of oxandrolone on height and skeletal maturation in uncomplicated growth retardation. Clinical Pharmacology and Therapeutics 12: 798–805, 1971

    CAS  Google Scholar 

  • Limberd JJ. Anabolic steroids in the training and treatment of athletics. Comprehensive Therapy 11: 25–30, 1985

    Google Scholar 

  • MacGillivray MH, Kolotkin M, Munschauer RW. Enhanced linear growth reponses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone. Pediatric Research 8: 103–108, 1974

    PubMed  CAS  Google Scholar 

  • Marti-Henneberg C, Niirianen AK, Rappaport R. Oxandrolone treatment of constitutional short stature in boys during adolescence: effect on linear growth, bone age, pubic hair, and testicular development. Journal of Pediatrics 86: 783–788, 1975

    PubMed  CAS  Google Scholar 

  • Mauss J, Borsch G, Bormacher K, Richter E, Leyendecker G, Nocke W. Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, testosterone, and seminal fluid analyses in normal men. Acta Endocrinologica 78: 373–384, 1975

    PubMed  CAS  Google Scholar 

  • Mayer M, Rosen F. Interaction of anabolic steroids with glucocorticoid receptor sites in rat muscle cytosol. American Journal of Physiology 229: 1381–1386, 1975

    PubMed  CAS  Google Scholar 

  • Mays ET, Christopherson W. Hepatic tumors induced by sex steroids. Seminars in Liver Disease 4: 147–157, 1984

    PubMed  CAS  Google Scholar 

  • McCaughan GW, Bilous MJ, Gallagher ND. Long-term survival with tumor regression in androgen-induced liver tumors. Cancer 56: 2622–2626, 1985

    PubMed  CAS  Google Scholar 

  • McKillop G, Todd IC, Ballantyne D. Increased left ventricular mass in a body builder using anabolic steroids. British Journal of Sports Medicine 20: 151–152, 1986

    PubMed  CAS  Google Scholar 

  • Meadows AT, Naimam JL, Valdes-Dapena M. Hepatoma associated with androgen therapy for aplastic anemia. Journal of Pediatrics 84: 109–110, 1974

    PubMed  CAS  Google Scholar 

  • Mellion MB. Anabolic steroids in athletics. American Family Practice 30: 113–119, 1984

    CAS  Google Scholar 

  • Michna H, Stang-Voss C. The predisposition to tendon rupture after doping with anabolic steroids. International Journal of Sports Medicine 4: 59, 1983

    Google Scholar 

  • Mokrohisky ST, Ambruso DR, Hathaway WE. Fulminant hepatic neoplasia after androgen therapy. New England Journal of Medicine 296: 1411–1412, 1977

    PubMed  CAS  Google Scholar 

  • Moldawer M. Anabolic agents: clinical efficacy versus side effects. Journal of the American Medical Women’s Association 23: 352–369, 1968

    PubMed  CAS  Google Scholar 

  • Molteni A, Brownie AC, Skelton FR. Production of hypertensive vascular disease in the rat by methyltestosterone. Laboratory Investigations 21: 129–137, 1969

    CAS  Google Scholar 

  • Molteni A, Skelton FR, Brownie AV. Effect of adrenalectomy on the development of androgen-induced hypertension. Laboratory Investigations 23: 429–435, 1970

    CAS  Google Scholar 

  • Moore DC, Tattoni DS, Limbeck GA, Ruvalcaba RHA, Lindner DS, et al. Studies of an anabolic steroid: V. Effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature. Pediatrics 58: 412–422, 1976

    CAS  Google Scholar 

  • Mosbach EH, Shefer S, Abell LL. Identification of the fecal metabolites of 17αmethyltestosterone in the dog. Journal of Lipid Research 9: 93–97, 1968

    PubMed  CAS  Google Scholar 

  • Mulvihill JJ, Ridolfi RL, Schultz FR, Borzy MS, Haughton PBT. Hepatic adenoma in Fanconi anemia treated with oxymetholone. Journal of Pediatrics 87: 122–124, 1975

    PubMed  CAS  Google Scholar 

  • Nagelberg SB, Laue L, Loriaux DL, Liu L, Sherns RJ. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. New England Journal of Medicine 314: 649–650, 1986

    PubMed  CAS  Google Scholar 

  • Nilsson B, Nilsson IM, Hedner U. Δ-4-Ethyl-estrenol in recurrent deep venous thrombosis. Acta Medica Scandinavica 209: 45–49, 1981

    PubMed  CAS  Google Scholar 

  • Noble RL. Androgen use by athletes: a possible cancer risk. Canadian Medical Association Journal 130: 549, 1984

    PubMed  CAS  Google Scholar 

  • O’Shea JP. Anabolic steroid: effects on competitive swimmers. Nutrition Reports International 1: 337–342, 1970

    Google Scholar 

  • O’Shea JP, Winkler W. Biochemical and physical effects of an anabolic steroid in competitive swimmers and weightlifters. Nutrition Reports International 2: 351–362, 1970

    Google Scholar 

  • Overbeek GA, DeVisser JA. A comparison of the myotropic and androgenic activities of the phenylpropionates and decanoates of testosterone and nandrolone. Acta Endocrinologica 38: 285–292, 1961

    PubMed  CAS  Google Scholar 

  • Overbeek GA, Vander Vies J, DeVisser J. The so-called ‘pure’ anabolic agents. Journal of the American Women’s Association 24: 54–59, 1969

    CAS  Google Scholar 

  • Overly WL, Dankoff JA, Wang BK, Singh VD. Androgens and hepatocellular carcinoma in an athlete. Annals of Internal Medicine 100: 158–159, 1984

    PubMed  CAS  Google Scholar 

  • Pertzelan A, Blum I, Grunebaum M, Laron A. The combined effect of growth hormone and methandrostenolone on the linear growth of patients with multiple pituitary hormone deficiencies. Clinical Endocrinology 6: 271–276, 1977

    PubMed  CAS  Google Scholar 

  • Pope Jr HG, Katz DL. Bodybuilder’s psychosis. Lancet 1: 863, 1987

    PubMed  Google Scholar 

  • Port RB, Petasnick JP, Ranniger K. Angiographic demonstration of hepatoma in association with Fanconi’s anemia. American Journal of Roentgenology 113: 82–83, 1971

    CAS  Google Scholar 

  • Potts GO, Arnold A, Beyler AL. Comparative myotrophic and nitrogen retaining effects of several steroids. Endocrinology 67: 849–854, 1960

    PubMed  CAS  Google Scholar 

  • Potts GO, Arnold A, Beyler AL. Dissociation of the androgenic and other hormonal activities from the protein anabolic effect of steroids. In Kochakian (Ed.) Handbook of experimental pharmacology, Vol. 43, Anabolic-androgenic steroids, pp. 361–406, Springer-Verlag, Berlin-Heidelberg, New York, 1976

    Google Scholar 

  • Raiti S, Trias E, Levitsky L, Grossman MS. Oxandrolone and human growth hormone. American Journal of Diseases in Children 126: 597–600, 1973

    CAS  Google Scholar 

  • Recant L, Lacy P. Fanconi’s anemia and hepatic cirrhosis. American Journal of Medicine 39: 464–475, 1965

    Google Scholar 

  • Remes K, Vuopio P, Jarvinen M, Harkonen M, Aldercreutz H. Effect of short-term treatment with an anabolic steroid (methandienone) and dehydroepiandrosterone sulphate on plasma hormones, red cell volume and 2,3-diphosphoglycerate in athletes. Scandinavian Journal of Clinical Laboratory Investigations 37: 577–586, 1977

    CAS  Google Scholar 

  • Richardson JR, Weinstein MB. Erythropoietic response of dialyzed patients to testosterone administration. Annals of Internal Medicine 73: 403–407, 1970

    PubMed  Google Scholar 

  • Roberts JT, Essenhigh DM. Adenocarcinoma of prostate in 40-year-old bodybuilder. Lancet 2: 742, 1987

    Google Scholar 

  • Robin JC, Suh OW, Ambrus JL. Studies on osteoporosis: VII. Effect of 17β-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis: a preliminary report. Steroids 40: 125–132, 1982

    CAS  Google Scholar 

  • Rogol AD. Drugs to enhance athletic performance in the adolescent. Seminars in Adolescent Medicine 1: 317–324, 1985

    PubMed  CAS  Google Scholar 

  • Rommerts FFG. How much androgen is required for spermatogenesis? Journal of Endocrinology 116: 7–9, 1988

    PubMed  CAS  Google Scholar 

  • Romshe CA, Sotos JF. The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency. Journal of Pediatrics 96: 127–131, 1980

    PubMed  CAS  Google Scholar 

  • Royer P, Rappaport R, Elsair S, Ciric O, Cachin O. A comparison of the action of hGH and anabolic steroids on growth rate in hypopituitary dwarfism. Annals of Endocrinology 31: 121–130, 1970

    CAS  Google Scholar 

  • Ruvalcaba RHA, Limbeck GA, Tatti DS, Moore DC, Kelley VC. Studies of anabolic steroids: VIII. Adult stature of males with Down syndrome treated with oxandrolone during childhood. Journal of Pediatrics 88: 504–505, 1976

    CAS  Google Scholar 

  • Ryan AJ. Anabolic steroids are fool’s gold. Federation Proceedings 40: 2682–2688, 1981

    PubMed  CAS  Google Scholar 

  • Saartok T, Dahlberg E, Gustafsson J-A. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology 114: 2100–2106, 1984

    PubMed  CAS  Google Scholar 

  • Sala G. Clinical evaluation of the anabolic effect of 4-hydroxy-17α-methyltestosterone. Helvetica Medica Acta 27: 519–522, 1960

    PubMed  CAS  Google Scholar 

  • Sale GE, Lerner KG. Multiple tumors after androgen therapy. Archives of Pathology and Laboratory Medicine 101: 600–603, 1977

    PubMed  CAS  Google Scholar 

  • Salt PJ. Inhibition of noradrenaline uptake2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. European Journal of Pharmacology 20: 329–340, 1972

    PubMed  CAS  Google Scholar 

  • Sanchez-Medal L, Gomez-Leal A, Duarte L, Rico MG. Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood 34: 283–300, 1969

    PubMed  CAS  Google Scholar 

  • Sarna G, Tamasulo P, Lotz MJ, Bubinak JF, Shulman NR. Multiple neoplasms in two siblings with a variant form of Fanconi’s anemia. Cancer 36: 1029–1033, 1975

    PubMed  CAS  Google Scholar 

  • Shapiro P, Ikeda RM, Ruebner BH, Connors MH, Halsted CC, et al. Multiple hepatic tumors and peliosis hepatis in Fanconi’s anemia treated with androgens. American Journal of Disease in Children 131: 1104–1106, 1977

    CAS  Google Scholar 

  • Shephard RJ, Killinger D, Fried T. Responses to sustained use of anabolic steroids. British Journal of Sports Medicine 11: 170–173, 1977

    PubMed  CAS  Google Scholar 

  • Shinohara K, Matsumoto N, Tajiri M. Oxymetholone treatment in aplastic anaemia. Acta Haematologica Japan 37: 255–265, 1974

    CAS  Google Scholar 

  • Shiozawa Z, Tsunoda S, Noda A, Saito M, Yamada H. Cerebral hemorrhagic infarction associated with anabolic steroid therapy for hypoplastic anemia. Angiology 37: 725–730, 1986

    PubMed  CAS  Google Scholar 

  • Shiozawa Z, Yamada H, Mabuchi C, Hotla T, Saito M, et al. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Annals of Neurology 12: 578–580, 1982

    PubMed  CAS  Google Scholar 

  • Simonson E, Kearns WM, Enzer N. Effect of methyl testosterone treatment on muscular performance and central nervous system of older men. Journal of Clinical Endocrinology 4: 528, 1944

    CAS  Google Scholar 

  • Snyder PJ, Lawrence DA. Treatment of male hypogonadism with testosterone enanthate. Journal of Clinical Endocrinology and Metabolism 51: 1335–1339, 1980

    PubMed  CAS  Google Scholar 

  • Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. Journal of the American Medical Association 253: 2871–2873, 1985

    PubMed  CAS  Google Scholar 

  • Strauss RH, Wright JE, Finerman GAM. Anabolic steroid use and health status among forty-two weight-trained male athletes. Abstract. Medicine and Science in Sports and Exercise 14: 119, 1982

    Google Scholar 

  • Stromeyer FW, Smith DH, Ishak KG. Anabolic steroid therapy and intrahepatic cholangiocarcinoma. Cancer 43: 440–443, 1979

    PubMed  CAS  Google Scholar 

  • Stromme SB, Meen HD, Aakvaag A. Effects of an androgenic-anabolic steroid on strength development and plasma testosterone levels in normal males. Medicine and Science in Sports 6: 203–208, 1974

    PubMed  CAS  Google Scholar 

  • Sweeney EC, Evans DJ. Hepatic lesions in patients treated with synthetic anabolic steroids. Journal of Clinical Pathology 29: 626–633, 1976

    PubMed  CAS  Google Scholar 

  • Tahmindjis AJ. The use of anabolic steroids by athletes to increase body weight and strength. Medical Journal of Australia 1: 991–993, 1976

    PubMed  CAS  Google Scholar 

  • Taggart HM, Applebaum-Bowden D, Haffner S, Warnick GR, Cheung MC, et al. Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. Metabolism 31: 1147–1152, 1982

    PubMed  CAS  Google Scholar 

  • Taylor WN. Anabolic steroids and the athlete, McFarland & Co. Inc, Jefferson, NC, 1982

    Google Scholar 

  • Taylor WN. Hormonal manipulation, McFarland & Co. Inc, Jefferson, NC, 1985

    Google Scholar 

  • Toth M, Zakar T. Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of “myotropic” and “androgenic” activities of 19-nortestosterone. Journal of Steroid Biochemistry 17: 653–660, 1982

    PubMed  CAS  Google Scholar 

  • Turani H, Levi J, Zevin D, Kessler E. Hepatic lesions in patients on anabolic androgenic therapy. Israel Journal of Medical Science 19: 332–337, 1983

    CAS  Google Scholar 

  • Tweedle D, Walton C, Johnston IDA. The effect of an anabolic steroid on postoperative nitrogen balance. British Journal of Clinical Practice 27: 130, 1972

    Google Scholar 

  • Van Arman CG, Drill VA. Some cardiovascular effects of nor-ethandrolone (Nilevar), testosterone, and progesterone. Journal of Pharmacology and Experimental Therapeutics 124: 59–63, 1958

    Google Scholar 

  • Vernon PE, McKinlay M. Effects of vitamin and hormone treatment on senile patients. Journal of Neurology, Neurosurgery and Psychiatry 9: 87, 1946

    CAS  Google Scholar 

  • Wakabayashi T, Onda H, Tada T, Iijima M, Itoh Y. High incidence of peliosis hepatis in autopsy cases of aplastic anemia with special reference to anabolic steroid therapy. Acta Pathologica Japonica 34: 1079–1086, 1984

    PubMed  CAS  Google Scholar 

  • Watson RN, Bradley MH, Callahan R, Peters BJ, Kory RC. A six month evaluation of an anabolic drug, norethandrolone, in underweight persons. I. Weight gain. American Journal of Medicine 26: 238–242, 1959

    CAS  Google Scholar 

  • Webb OL, Laskarzewski PM, Clueck GJ. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 33: 971–975, 1984

    PubMed  CAS  Google Scholar 

  • Weinstein Y, Berkovich Z. Testosterone effect on bone marrow, thymus, and suppressor T cells in the (NZBXNZW) Fl. mice: its relevance to autoimmunity. Journal of Immunology 126: 998–1002, 1981

    CAS  Google Scholar 

  • Westaby D, Ogle SJ, Paradinas FJ, Randell JB, Murray-Lyon IM. Liver damage from long-term methyltestosterone. Lancet 1: 261–263, 1977

    Google Scholar 

  • Westaby D, Portmann B, Williams R. Androgen related primary hepatic tumors on non-Fanconi patients. Cancer 51: 1947–1952, 1983

    PubMed  CAS  Google Scholar 

  • Whitelaw MJ, Foster TN, Graham WH. Steroidal induction of the premature growth spurt in prepubertal boys for excessive height. Acta Endocrinologica 50: 317–320, 1965

    PubMed  CAS  Google Scholar 

  • Wilson JD, Griffin JE. The use and misuse of androgens. Metabolism 29: 1278–1295, 1980

    PubMed  CAS  Google Scholar 

  • Wolf CB, Mellinger RC, Morrow LB, Zafar MS. The effectiveness of oxandrolone in promoting linear growth in growth hormone deficient children. Henry Ford Hospital Medical Journal 21: 163–167, 1973

    Google Scholar 

  • Wood PD, Haskel WL, Klein H. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism 25: 1249–1257, 1976

    PubMed  CAS  Google Scholar 

  • Woodard TL, Burghen GA, Kitabchi AE, Wilimas JA. Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. Journal of Clinical Endocrinology and Metabolism 53: 905–908, 1981

    PubMed  CAS  Google Scholar 

  • Wright JE. Anabolic steroids and athletics. In Hutton & Miller (Eds) Exercise and sports science reviews, pp. 149–202, Academic, New York, 1980

    Google Scholar 

  • Zachmann M, Ferrandez A, Mursett G, Gnehm HE, Prader A. Testosterone treatment of excessively tall boys. Journal of Pediatrics 88: 116–123, 1976

    PubMed  CAS  Google Scholar 

  • Zachmann M, Prader A. Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone. Journal of Clinical Endocrinology 30: 85–95, 1970

    CAS  Google Scholar 

  • Zeiss J, Smith RR, Taha AM. Iliopsoas hypertrophy mimicking acute abdomen in a bodybuilder. Gastrointestinal Radiology 12: 340–342, 1987

    PubMed  CAS  Google Scholar 

  • Ziegenfuss J, Carabasi R. Androgens and hepatocellular carcinoma. Lancet 1: 262, 1973

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Education, University of Illinois at Chicago, Box 4348, Chicago, Illinois, 60680, USA

    Robert C. Hickson, Karen L. Ball & Michael T. Falduto

Authors
  1. Robert C. Hickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen L. Ball
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael T. Falduto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hickson, R.C., Ball, K.L. & Falduto, M.T. Adverse Effects of Anabolic Steroids. Med Toxicol Adverse Drug Exp 4, 254–271 (1989). https://doi.org/10.1007/BF03259912

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259912

Keywords

Search

Navigation